Temple Health hospital CEO steps down

John Cacciamani, MD, is stepping down from his role as president and CEO of  Philadelphia-based Chestnut Hill Hospital, part of Philadelphia-based Temple Health, effective immediately. 

Advertisement

Jeremy Slaga, chief integration officer at Temple Health, is stepping in as interim CEO while the hospital searches for a permanent CEO, according to a March 5 news release shared with Becker’s.

Rebecca Gubanich, vice president of finance, and Scott Friend, vice president and chief quality officer, are also stepping down from their roles at Chestnut Hill Hospital.

Gerald Oetzel, chief financial officer of Temple Health, will take over Chestnut Hill Hospital’s financial operations.

Carl Sirio, MD, chief medical officer of Temple Health, will oversee the hospital’s clinical quality and safety initiatives, infection prevention, clinical risk mitigation, and medical staff affairs and relations. Dr. Sirio will work closely with James Helstrom, MD, the hospital’s interim CMO and CMO of Philadelphia-based Fox Chase Cancer Center. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.